Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 159

1.

Genetic factors associated with elevation of uric acid after treatment with thiazide-like diuretic in patients with essential hypertension.

Ohta Y, Kamide K, Hanada H, Morimoto S, Nakahashi T, Takiuchi S, Ishimitsu T, Tsuchihashi T, Soma M, Tomohiro Katsuya T, Sugimoto K, Rakugi H, Oukura T, Higaki J, Matsuura H, Shinagawa T, Miwa Y, Sasaguri T, Igase M, Miki T, Takeda K, Higashiura K, Shimamoto K, Katabuchi R, Ueno M, Hosomi N, Kato J, Komai N, Kojima S, Sase K, Iwashima Y, Yoshihara F, Horio T, Nakamura S, Nakahama H, Miyata T, Kawano Y.

Hypertens Res. 2020 Mar;43(3):220-226. doi: 10.1038/s41440-019-0356-x. Epub 2019 Nov 20.

PMID:
31748705
2.

Association Between Circadian Hemodynamic Characteristics and Target Organ Damage in Patients With Essential Hypertension.

Kusunoki H, Iwashima Y, Kawano Y, Hayashi SI, Kishida M, Horio T, Shinmura K, Yoshihara F.

Am J Hypertens. 2019 Jul 17;32(8):742-751. doi: 10.1093/ajh/hpz088.

PMID:
31211373
3.

Circadian hemodynamic characteristics in hypertensive patients with primary aldosteronism.

Kusunoki H, Iwashima Y, Kawano Y, Hayashi SI, Kishida M, Horio T, Shinmura K, Yoshihara F.

J Hypertens. 2018 Nov;36(11):2260-2268. doi: 10.1097/HJH.0000000000001800.

PMID:
29846324
4.

Inversion of Qubit Energy Levels in Qubit-Oscillator Circuits in the Deep-Strong-Coupling Regime.

Yoshihara F, Fuse T, Ao Z, Ashhab S, Kakuyanagi K, Saito S, Aoki T, Koshino K, Semba K.

Phys Rev Lett. 2018 May 4;120(18):183601. doi: 10.1103/PhysRevLett.120.183601.

PMID:
29775324
5.

An Exploratory Study of Dapagliflozin for the Attenuation of Albuminuria in Patients with Heart Failure and Type 2 Diabetes Mellitus (DAPPER).

Yoshihara F, Imazu M, Hamasaki T, Anzai T, Yasuda S, Ito S, Yamamoto H, Hashimura K, Yasumura Y, Mori K, Watanabe M, Asakura M, Kitakaze M; DAPPER investigators and study coordinators.

Cardiovasc Drugs Ther. 2018 Apr;32(2):183-190. doi: 10.1007/s10557-018-6782-1.

PMID:
29589153
6.

Factors Associated with Outcomes of Percutaneous Transluminal Renal Angioplasty in Patients with Renal Artery Stenosis: A Retrospective Analysis of 50 Consecutive Cases.

Matayoshi T, Kamide K, Tanaka R, Fukuda T, Horio T, Iwashima Y, Yoshihara F, Nakamura S, Nakahama H, Ohya Y, Kawano Y.

Int J Hypertens. 2018 Jan 4;2018:1952685. doi: 10.1155/2018/1952685. eCollection 2018.

7.

Association between renal function and outcomes after percutaneous transluminal renal angioplasty in hypertensive patients with renal artery stenosis.

Iwashima Y, Fukuda T, Horio T, Hayashi SI, Kusunoki H, Kishida M, Nakamura S, Kamide K, Kawano Y, Yoshihara F.

J Hypertens. 2018 Jan;36(1):126-135. doi: 10.1097/HJH.0000000000001499.

PMID:
28786860
8.

High Stroke Volume Variation Is an Independent Predictor for Decreased Blood Pressure During Hemodialysis.

Yoshihara F, Kishida M, Ogawa K, Nishigaki T, Nakasaki H, Ishizuka A, Koezuka R, Matsuo M, Hayashi T, Nakamura S.

Ther Apher Dial. 2017 Apr;21(2):166-172. doi: 10.1111/1744-9987.12511. Epub 2017 Mar 10.

PMID:
28296183
9.

Impact of decreased serum albumin levels on acute kidney injury in patients with acute decompensated heart failure: a potential association of atrial natriuretic peptide.

Takaya Y, Yoshihara F, Yokoyama H, Kanzaki H, Kitakaze M, Goto Y, Anzai T, Yasuda S, Ogawa H, Kawano Y, Kangawa K.

Heart Vessels. 2017 Aug;32(8):932-943. doi: 10.1007/s00380-017-0954-y. Epub 2017 Feb 7.

PMID:
28176004
10.

Preventive effect of renin-angiotensin system inhibitors on new-onset atrial fibrillation in hypertensive patients: a propensity score matching analysis.

Horio T, Akiyama M, Iwashima Y, Yoshihara F, Nakamura S, Tokudome T, Okutsu M, Tanaka H, Komatsubara I, Okimoto N, Kamakura S, Kawano Y.

J Hum Hypertens. 2017 Jul;31(7):450-456. doi: 10.1038/jhh.2016.95. Epub 2016 Dec 29.

PMID:
28032630
11.

Suppressing relaxation in superconducting qubits by quasiparticle pumping.

Gustavsson S, Yan F, Catelani G, Bylander J, Kamal A, Birenbaum J, Hover D, Rosenberg D, Samach G, Sears AP, Weber SJ, Yoder JL, Clarke J, Kerman AJ, Yoshihara F, Nakamura Y, Orlando TP, Oliver WD.

Science. 2016 Dec 23;354(6319):1573-1577. doi: 10.1126/science.aah5844. Epub 2016 Dec 8.

PMID:
27940578
12.

Effects of Percutaneous Transluminal Renal Angioplasty on Office and Home Blood Pressure and Home Blood Pressure Variability in Hypertensive Patients With Renal Artery Stenosis.

Iwashima Y, Fukuda T, Kusunoki H, Hayashi SI, Kishida M, Yoshihara F, Nakamura S, Kamide K, Horio T, Kawano Y.

Hypertension. 2017 Jan;69(1):109-117. Epub 2016 Nov 21.

PMID:
27872233
13.

Effective uric acid-lowering treatment for hypertensive patients with hyperuricemia.

Ohta Y, Ishizuka A, Arima H, Hayashi S, Iwashima Y, Kishida M, Yoshihara F, Nakamura S, Kawano Y.

Hypertens Res. 2017 Mar;40(3):259-263. doi: 10.1038/hr.2016.139. Epub 2016 Oct 20.

PMID:
27760998
14.

Effects of cigarette smoking on ambulatory blood pressure, heart rate, and heart rate variability in treated hypertensive patients.

Ohta Y, Kawano Y, Hayashi S, Iwashima Y, Yoshihara F, Nakamura S.

Clin Exp Hypertens. 2016;38(6):510-3. doi: 10.3109/10641963.2016.1148161. Epub 2016 Jul 8.

PMID:
27391795
15.

Systemic Inflammation Is a Key Factor for Mortality Risk Stratification in Chronic Kidney Disease Patients With Coronary Artery Calcification.

Yoshihara F.

Circ J. 2016 Jun 24;80(7):1537-8. doi: 10.1253/circj.CJ-16-0506. Epub 2016 Jun 3. No abstract available.

16.

Incidence and risk factors for restenosis, and its impact on blood pressure control after percutaneous transluminal renal angioplasty in hypertensive patients with renal artery stenosis.

Iwashima Y, Fukuda T, Yoshihara F, Kusunoki H, Kishida M, Hayashi S, Nakamura S, Kamide K, Horio T, Kawano Y.

J Hypertens. 2016 Jul;34(7):1407-15. doi: 10.1097/HJH.0000000000000928.

PMID:
27065003
17.

Trends in the awareness of salt restriction and actual salt intake in hypertensive patients at a hypertension clinic and general clinic: A one-year follow-up study.

Ohta Y, Ohta K, Ishizuka A, Hayashi S, Kishida M, Iwashima Y, Yoshihara F, Nakamura S, Kawano Y.

Clin Exp Hypertens. 2015;37(6):454-8. doi: 10.3109/10641963.2015.1057835.

PMID:
26395951
18.

Why Is Proteinuria an Independent Risk Factor for Contrast-Induced Nephropathy?

Yoshihara F.

Circ J. 2015;79(7):1456-7. doi: 10.1253/circj.CJ-15-0556. Epub 2015 Jun 1. No abstract available.

19.

Effects of a selective aldosterone blocker and thiazide-type diuretic on blood pressure and organ damage in hypertensive patients.

Ohta Y, Ishizuka A, Hayashi S, Iwashima Y, Kishida M, Yoshihara F, Nakamura S, Kawano Y.

Clin Exp Hypertens. 2015;37(7):569-73. doi: 10.3109/10641963.2015.1026041. Epub 2015 May 20.

PMID:
25992488
20.

Related factors for worsening renal function following percutaneous transluminal renal angioplasty (PTRA) in patients with atherosclerotic renal artery stenosis.

Yoshihara F, Fukuda T, Iwashima Y, Nakamura S, Hayashi S, Kishida M, Ishizuka A, Kusunoki H, Ohta Y, Kawano Y.

Clin Exp Hypertens. 2015;37(7):526-30. doi: 10.3109/10641963.2015.1013125. Epub 2015 Apr 28.

PMID:
25919953
21.

Risk Stratification of Acute Kidney Injury Using the Blood Urea Nitrogen/Creatinine Ratio in Patients With Acute Decompensated Heart Failure.

Takaya Y, Yoshihara F, Yokoyama H, Kanzaki H, Kitakaze M, Goto Y, Anzai T, Yasuda S, Ogawa H, Kawano Y.

Circ J. 2015;79(7):1520-5. doi: 10.1253/circj.CJ-14-1360. Epub 2015 Apr 8.

22.

Effects of daily walking on office, home and 24-h blood pressure in hypertensive patients.

Ohta Y, Kawano Y, Minami J, Iwashima Y, Hayashi S, Yoshihara F, Nakamura S.

Clin Exp Hypertens. 2015;37(5):433-7. doi: 10.3109/10641963.2015.1013115. Epub 2015 Mar 27.

PMID:
25815710
23.

Awareness of salt restriction and actual salt intake in hypertensive patients at a hypertension clinic and general clinic.

Ohta Y, Ohta K, Ishizuka A, Hayashi S, Kishida M, Iwashima Y, Yoshihara F, Nakamura S, Kawano Y.

Clin Exp Hypertens. 2015;37(2):172-5. doi: 10.3109/10641963.2014.933965. Epub 2014 Dec 12.

PMID:
25496285
24.

Impact of onset time of acute kidney injury on outcomes in patients with acute decompensated heart failure.

Takaya Y, Yoshihara F, Yokoyama H, Kanzaki H, Kitakaze M, Goto Y, Anzai T, Yasuda S, Ogawa H, Kawano Y.

Heart Vessels. 2016 Jan;31(1):60-5. doi: 10.1007/s00380-014-0572-x. Epub 2014 Aug 24.

PMID:
25150587
25.

Aggravated renal tubular damage and interstitial fibrosis in mice lacking guanylyl cyclase-A (GC-A), a receptor for atrial and B-type natriuretic peptides.

Yoshihara F, Tokudome T, Kishimoto I, Otani K, Kuwabara A, Horio T, Kawano Y, Kangawa K.

Clin Exp Nephrol. 2015 Apr;19(2):197-207. doi: 10.1007/s10157-014-0982-1. Epub 2014 May 21.

PMID:
24845230
26.

Trend of office and home blood pressure control in treated hypertensive patients: changes in antihypertensive medication and salt intake.

Ohta Y, Iwashima Y, Hayashi S, Yoshihara F, Nakamura S, Kamide K, Horio T, Kawano Y.

Clin Exp Hypertens. 2014;36(2):103-7. doi: 10.3109/10641963.2014.892118.

PMID:
24625337
27.

Rotating-frame relaxation as a noise spectrum analyser of a superconducting qubit undergoing driven evolution.

Yan F, Gustavsson S, Bylander J, Jin X, Yoshihara F, Cory DG, Nakamura Y, Orlando TP, Oliver WD.

Nat Commun. 2013;4:2337. doi: 10.1038/ncomms3337.

PMID:
23945930
28.

Control of home blood pressure with an amlodipine- or losartan-based regimen and progression of carotid artery intima-media thickness in hypertensive patients: the HOSP substudy.

Ohta Y, Kawano Y, Iwashima Y, Hayashi S, Yoshihara F, Matayoshi T, Takiuchi S, Kamide K, Nakamura S, Horio T.

Clin Exp Hypertens. 2013;35(4):279-84. doi: 10.3109/10641963.2013.780074. Epub 2013 Mar 26.

PMID:
23530977
29.

Response to renal resistive index and cardiovascular and renal outcomes in essential hypertension.

Doi Y, Iwashima Y, Yoshihara F, Kamide K, Hayashi S, Kubota Y, Nakamura S, Horio T, Kawano Y.

Hypertension. 2013 Feb;61(2):e23. No abstract available. Erratum in: Hypertension. 2013 May;61(5):e48. Yoshihara, Fumiki [added]; Kamide, Kei [added]; Hayash, Shin-ichiro [added]; Kubota, Yoshinori [added]; Nakamura, Satoko [added]; Horio, Takeshi [added].

PMID:
23444464
30.

Improving quantum gate fidelities by using a qubit to measure microwave pulse distortions.

Gustavsson S, Zwier O, Bylander J, Yan F, Yoshihara F, Nakamura Y, Orlando TP, Oliver WD.

Phys Rev Lett. 2013 Jan 25;110(4):040502. Epub 2013 Jan 24.

PMID:
25166145
31.

Effect of bezafibrate on office, home and ambulatory blood pressure in hypertensive patients with dyslipidemia.

Ohta Y, Kawano Y, Iwashima Y, Hayashi S, Yoshihara F, Nakamura S.

J Hum Hypertens. 2013 Jul;27(7):417-20. doi: 10.1038/jhh.2012.64. Epub 2012 Dec 20.

PMID:
23254592
32.

Dynamical decoupling and dephasing in interacting two-level systems.

Gustavsson S, Yan F, Bylander J, Yoshihara F, Nakamura Y, Orlando TP, Oliver WD.

Phys Rev Lett. 2012 Jul 6;109(1):010502. Epub 2012 Jul 3.

PMID:
23031094
33.

Association of renal resistive index with target organ damage in essential hypertension.

Doi Y, Iwashima Y, Yoshihara F, Kamide K, Takata H, Fujii T, Kubota Y, Nakamura S, Horio T, Kawano Y.

Am J Hypertens. 2012 Dec;25(12):1292-8. doi: 10.1038/ajh.2012.113. Epub 2012 Aug 9.

PMID:
22874890
34.

Renal resistive index and cardiovascular and renal outcomes in essential hypertension.

Doi Y, Iwashima Y, Yoshihara F, Kamide K, Hayashi S, Kubota Y, Nakamura S, Horio T, Kawano Y.

Hypertension. 2012 Sep;60(3):770-7. doi: 10.1161/HYPERTENSIONAHA.112.196717. Epub 2012 Jul 23.

PMID:
22824987
35.

Driven dynamics and rotary echo of a qubit tunably coupled to a harmonic oscillator.

Gustavsson S, Bylander J, Yan F, Forn-Díaz P, Bolkhovsky V, Braje D, Fitch G, Harrabi K, Lennon D, Miloshi J, Murphy P, Slattery R, Spector S, Turek B, Weir T, Welander PB, Yoshihara F, Cory DG, Nakamura Y, Orlando TP, Oliver WD.

Phys Rev Lett. 2012 Apr 27;108(17):170503. Epub 2012 Apr 27.

PMID:
22680846
36.

Kidney function and histological damage in autopsy subjects with myocardial infarction.

Niizuma S, Nakamura S, Ishibashi-Ueda H, Yoshihara F, Kawano Y.

Ren Fail. 2011;33(9):847-52. doi: 10.3109/0886022X.2011.605531. Epub 2011 Aug 8.

PMID:
21823900
37.

Association of intima-media thickening of carotid artery with genetic polymorphisms of the regulator of G-protein signaling 2 gene in patients with hypertension and in the general population.

Kamide K, Kokubo Y, Yang J, Takiuchi S, Horio T, Matsumoto S, Banno M, Matayoshi T, Yasuda H, Miwa Y, Yoshihara F, Nakamura S, Nakahama H, Iwashima Y, Oguro R, Ohishi M, Rakugi H, Okamura T, Miyata T, Kawano Y.

Hypertens Res. 2011 Jun;34(6):740-6. doi: 10.1038/hr.2011.25. Epub 2011 Mar 31.

PMID:
21451528
38.

Evidence for severe atherosclerotic changes in chronic hemodialysis patients: comparative autopsy study against cardiovascular disease patients without chronic kidney disease.

Suzuki C, Nakamura S, Ishibashi-Ueda H, Yoshihara F, Kawano Y.

Ther Apher Dial. 2011 Feb;15(1):51-7. doi: 10.1111/j.1744-9987.2010.00873.x. Epub 2010 Oct 29.

PMID:
21272253
39.

Interleukin-6 as an independent predictor of future cardiovascular events in high-risk Japanese patients: comparison with C-reactive protein.

Nishida H, Horio T, Suzuki Y, Iwashima Y, Tokudome T, Yoshihara F, Nakamura S, Kawano Y.

Cytokine. 2011 Mar;53(3):342-6. doi: 10.1016/j.cyto.2010.12.005. Epub 2010 Dec 28.

PMID:
21190868
40.

Blood pressure and medication during long-term antihypertensive therapy based on morning home SBP in hypertensive patients: Hypertension Control Based on Home Systolic Pressure (HOSP) substudy.

Kawano Y, Horio T, Kamide K, Iwashima Y, Yoshihara F, Nakamura S.

Clin Exp Hypertens. 2010 Jul;32(4):239-43. doi: 10.3109/10641963.2010.491889.

PMID:
20608895
41.

Chronic kidney disease as an independent risk factor for new-onset atrial fibrillation in hypertensive patients.

Horio T, Iwashima Y, Kamide K, Tokudome T, Yoshihara F, Nakamura S, Kawano Y.

J Hypertens. 2010 Aug;28(8):1738-44. doi: 10.1097/HJH.0b013e32833a7dfe.

PMID:
20485194
42.

Additive interaction of metabolic syndrome and chronic kidney disease on cardiac hypertrophy, and risk of cardiovascular disease in hypertension.

Iwashima Y, Horio T, Kamide K, Tokudome T, Yoshihara F, Nakamura S, Ogihara T, Rakugi H, Kawano Y.

Am J Hypertens. 2010 Mar;23(3):290-8. doi: 10.1038/ajh.2009.253. Epub 2009 Dec 31.

PMID:
20044739
43.

Coronary calcification in patients with chronic kidney disease and coronary artery disease.

Nakamura S, Ishibashi-Ueda H, Niizuma S, Yoshihara F, Horio T, Kawano Y.

Clin J Am Soc Nephrol. 2009 Dec;4(12):1892-900. doi: 10.2215/CJN.04320709. Epub 2009 Oct 15.

44.

Association of insulin-like growth factor-1 receptor gene polymorphisms with left ventricular mass and geometry in essential hypertension.

Horio T, Kamide K, Takiuchi S, Yoshii M, Miwa Y, Matayoshi T, Yoshihara F, Nakamura S, Tokudome T, Miyata T, Kawano Y.

J Hum Hypertens. 2010 May;24(5):320-6. doi: 10.1038/jhh.2009.73. Epub 2009 Sep 17.

PMID:
19759555
45.

Effects of long-term intravenous administration of adrenomedullin (AM) plus hANP therapy in acute decompensated heart failure: a pilot study.

Nishikimi T, Karasawa T, Inaba C, Ishimura K, Tadokoro K, Koshikawa S, Yoshihara F, Nagaya N, Sakio H, Kangawa K, Matsuoka H.

Circ J. 2009 May;73(5):892-8. Epub 2009 Apr 2.

46.

Intratracheal gene transfer of adrenomedullin using polyplex nanomicelles attenuates monocrotaline-induced pulmonary hypertension in rats.

Harada-Shiba M, Takamisawa I, Miyata K, Ishii T, Nishiyama N, Itaka K, Kangawa K, Yoshihara F, Asada Y, Hatakeyama K, Nagaya N, Kataoka K.

Mol Ther. 2009 Jul;17(7):1180-6. doi: 10.1038/mt.2009.63. Epub 2009 Mar 31.

47.

Genetic polymorphisms of L-type calcium channel alpha1C and alpha1D subunit genes are associated with sensitivity to the antihypertensive effects of L-type dihydropyridine calcium-channel blockers.

Kamide K, Yang J, Matayoshi T, Takiuchi S, Horio T, Yoshii M, Miwa Y, Yasuda H, Yoshihara F, Nakamura S, Nakahama H, Miyata T, Kawano Y.

Circ J. 2009 Apr;73(4):732-40. Epub 2009 Feb 17.

48.

Renal artery stenosis and renal parenchymal damage in patients with abdominal aortic aneurysm proven by autopsy.

Nakamura S, Ishibashi-Ueda H, Suzuki C, Nakata H, Yoshihara F, Nakahama H, Kawano Y.

Kidney Blood Press Res. 2009;32(1):11-6. doi: 10.1159/000197865. Epub 2009 Jan 29.

49.

The cutoff value of aldosterone-to-renin ratio for the diagnosis of primary aldosteronism in patients taking antihypertensive medicine.

Niizuma S, Nakahama H, Kamide K, Fukuchi K, Iwanaga Y, Nakata H, Yoshihara F, Horio T, Nakamura S, Kawano Y.

Clin Exp Hypertens. 2008 Oct;30(7):640-7. doi: 10.1080/10641960802443282.

PMID:
18855267
50.

Associations of hypertension and its complications with variations in the xanthine dehydrogenase gene.

Yang J, Kamide K, Kokubo Y, Takiuchi S, Horio T, Matayoshi T, Yasuda H, Miwa Y, Yoshii M, Yoshihara F, Nakamura S, Nakahama H, Tomoike H, Miyata T, Kawano Y.

Hypertens Res. 2008 May;31(5):931-40. doi: 10.1291/hypres.31.931.

PMID:
18712049

Supplemental Content

Loading ...
Support Center